Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a quarterly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

**IMPORTANT** The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over seven years to fund the Beau Biden Cancer Moonshot Initiative. The National Cancer Institute has released numerous funding opportunity announcements, and additional funding initiatives are anticipated. You are encouraged to visit their website for a complete and current list of funding opportunities that may be available to you.

Posted July 12, 2021

Susan G. Komen Career Catalyst Research (CCR) Grants

LOI Deadline: Jul 26, 2021
Requirements: To be considered, please email a one-page research proposal  and biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.
Full Letter of Intent instructions: Click here to visit their website.


Posted July 2, 2021

NIH National Cancer Institute Requests for Applications (RFAs)

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

LOI Deadline: July 6, 2021
Application Deadline: August 6, 2021
How to Apply: Visit their website

The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date.
Application Deadline: September 9, 2021
How to Apply: Visit their website

The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date.
Application Deadline: September 9, 2021
How to Apply: Visit their website

The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)

LOI Deadline: 30 days prior to the application due date
Application Deadline: September 9, 2021
How to Apply: Visit their website

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date
Application Deadline: September 29, 2021
How to Apply: Visit their website

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date
Application Deadline: September 29, 2021
How to Apply: Visit their website

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date
Application Deadline: September 29, 2021
How to Apply: Visit their website

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

LOI Deadline: 30 days prior to the application due date
Application Deadline: September 29, 2021
How to Apply: Visit their website

Notice of Special Interest: Administrative Supplements for Cancer Moonshot awardees and Cancer Center Support Grants (CCSG) to Support Development of an "Immune Radiation Response Index (iRRI)" for Immune Cells from Normal and Tumor Microenvironments

LOI Deadline: 30 days prior to the application due date.
Application Deadline: July 31, 2021
How to Apply: Visit their website

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

LOI Deadline: July 20, 2021
Application Deadline: August 24, 2021
How to Apply: Visit their website

Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)

LOI Deadline: 30 days prior to the application due date.
Application Deadline: August 20, 2021
How to Apply: Visit their website

Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional)

LOI Deadline: September 13, 2021
Application Deadline: October 13, 2021
How to Apply: Visit their website


Posted May 20, 2021

2021 Gabrielle's Angel Foundation Conventional and Integrative Grants

Deadline: proposal to the Cancer Center due Friday, June 11, 2021 / full application due Friday, August 27, 2021

How to apply: Please email one or two paragraphs on your proposal and biosketch to Nancy Presseau at npresseau@mednet.ucla.edu

About the award: Gabrielle’s Angel Foundation for Cancer Research is soliciting grant applications to fund innovative and insightful medical research. Gabrielle’s Angel has focused on supporting promising junior investigators conducting scientific research that can be applied to improving the treatment of patients with these diseases. Gabrielle’s Angel has invited the JCCC to nominate only one application per category/per institution for their Conventional and Integrative grants.

Conventional grants are conventional or mainstream projects. Integrative grants are integrative research projects that explore evidence-based complementary interventions such as acupuncture, nutrition, meditation, yoga, etc. Also supports clinical trials and/or pre-clinical research that addresses reducing patients’ physical and emotional distress during or after cancer therapy.

The award for each grant is $75,000 a year for 3 years. Overhead/indirect costs may not exceed 10% of the total grant award.